Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs DBX✓SelectedUSD · DBXGSK vs DBX performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs DBX

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
DBX return
+25.0%
Excess return
+27.7%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioDBXExcessAlpha
1D-0.1%+0.3%-0.5%-0.1%
7D-5.3%+1.1%-6.5%-5.3%
30D-3.7%-7.3%+3.7%-3.6%
3M-7.3%-0.3%-7.0%-7.2%
6M-4.2%+23.0%-27.3%-3.9%
YTD+0.9%+22.0%-21.1%+1.6%
1Y+7.3%+17.5%-10.3%+8.1%
3Y+52.7%+22.4%+30.3%+50.3%
All+52.7%+25.0%+27.7%+50.3%

Cumulative growth

Daily Returns

Daily percentage return beside DBX.

Daily Out/Under-Performance

Portfolio return minus DBX return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × DBX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded DBX wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling